新辅助剂低剂量放射治疗加上杜尔瓦卢马布和化学疗法,用于潜在可切除的III期NSCLC:一项Ib期剂量升级研究
概括
新辅助性低剂量放射治疗 (LDRT) 与杜尔瓦卢马布和化疗相结合,对可切除的第三阶段非小细胞肺癌 (NSCLC) 有望. 最佳剂量为30 Gy分为15个分量,耐受性良好,并显示出显著的疗效.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 免疫治疗是一种免疫疗法.
背景情况:
- 第三阶段非小细胞肺癌 (NSCLC) 对治疗提出了挑战.
- 新辅助疗法旨在改善切除能力和结果.
- 将低剂量放射治疗 (LDRT) 与免疫疗法和化疗相结合是一种新兴的策略.
研究的目的:
- 评估新辅助剂LDRT加上杜尔瓦卢马布和化疗的安全性和耐受性.
- 评估这种组合治疗方案的初步抗瘤活性.
- 为了确定潜在可切除III期NSCLC的最佳辐射剂量升级.
主要方法:
- 一个3+3剂量升级设计的Ib期研究.
- 三个队列接受了不断升级的LDRT剂量 (10,20或30 Gy) 与同时进行杜尔瓦卢马布和化疗.
- 主要终点:安全性和耐受性;次要终点:主要病理反应 (MPR),病理完整反应 (pCR),无事件生存期 (EFS).
主要成果:
- 组合疗法耐受性良好,没有剂量限制性毒性.
- 9名患者中有7名 (77.8%) 实现了R0切除.
- 观察到MPR (高达100%) 和pCR (高达66.7%) 的高率,特别是在最高剂量队列中.
- 在30 Gy队列中,12个月的EFS率达到100%.
结论:
- 新辅助剂LDRT加上杜尔瓦卢马布和化疗对于潜在可切除的III期NSCLC是安全的和可以容忍的.
- 最佳的放射治疗剂量被确定为30 Gy分为15个小部分.
- 这种联合疗法显示出有前途的初步疗效,需要进一步研究.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.8K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
